期刊文献+

大麻素系统与胃肠道内脏痛调控关系的研究进展

Progress in Study on Relationship between Cannabinoids and Regulation of Visceral Pain of Gastrointestinal Tract
下载PDF
导出
摘要 腹痛是功能性胃肠病(FGIDs),特别是肠易激综合征(IBS)的主要症状之一,严重影响患者的生活质量。然而,其病理生理学机制复杂且仍未明确。大麻素已被应用于疼痛机制的研究和临床治疗,但成瘾性等中枢系统不良反应限制了其应用。因此,研究大麻素系统的外周作用途径,对提高大麻素治疗慢性疼痛(特别是内脏痛)的效果,具有重要意义。本文就大麻素系统与胃肠道内脏痛调控关系的研究进展作一综述。 Abdominal pain is one of the main symptoms of functional gastrointestinal disorders (FGIDs), especially the irritable bowel syndrome (IBS), which severely affects the life quality of patients. However, its pathophysiologie mechanism is complicated and has not been clarified. Cannabinoids has been applied in studies on the mechanism of pain and in clinical treatment, but addiction and other central nervous system side effects have restricted its application. Therefore, the study on peripheral action of cannabinoids is of great significance in raising the efficacy of cannabinoids on curing chronic pain (especially visceral pain). This article reviewed the progress in investigating on the relationship between cannabinoids and regulation of visceral pain of gastrointestinal tract.
出处 《胃肠病学》 2011年第6期376-378,共3页 Chinese Journal of Gastroenterology
关键词 内源性大麻酚类 内脏痛 受体 大麻酚 中枢神经系统 周围神经系统 Endocannabinoids Visceral Pain Receptors, Cannabinoid Central Nervous System Peripheral Nervous System
  • 相关文献

参考文献22

  • 1Fride E. The endogenous cannabinoid system: a new player in the brain-gut-adipose axis. Cannabinoids, 2007, 2 (2): 5-12.
  • 2Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev, 2002, 54 (2): 161-202.
  • 3Hohmann AG, Suplita RL 2nd. Endocannabinoid mechanisms of pain modulation. AAPS J, 2006, 8 (4): E693-E708.
  • 4Delgado-Aros S, Camilleri M. Visceral hypersensitivity. J Clin Gastroenterol, 2005, 39 (5 Suppl 3): S194-$203.
  • 5Chen SL, Wu XY, Cao ZJ, et al. Subdiaphragmatic vagal afferent nerves modulate visceral pain. Am J Physiol Gastrointest Liver Physiol, 2008, 294 (6): G1441-G1449.
  • 6Chen S, Li J, Zhang L, et al. 5-HT3 receptors mediate the time-dependent vagal afferent modulation of nociception during chronic food allergen-sensitized visceral hyperalgesia in rats. Neurogastroenterol Motil, 2009, 21 (11): 1222-el 13.
  • 7Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity: facts, speculations, and challenges. Gut, 2001, 48 (1): 125-131.
  • 8Mertz I-I, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology, 2000, 118 (5): 842-848.
  • 9Mayer EA, Naliboff BD, Craig AD. Neuroimaging of the brain-gut axis: from basic understanding to treatment offunctional GI disorders. Gastroenterology, 2006, 131 (6): 1925-1942.
  • 10Gao J, Wu X, Owyang C, et al. Enhanced responses of the anterior cingulate cortex neurones to colonic distension in viscerally hypersensitive rats. J Physiol, 2006, 570 (Pt 1): 169-183.

二级参考文献15

  • 1Pertwee RG.The pharmacology of cannabinoid receptors and their ligands an overview.Int J Obes(Lond),2006,30:13-18.
  • 2Woelkart K,Salo-Ahen OM,Bauer R.CB receptor ligands from plants.Curr Top Med Chem,2008,8:173-186.
  • 3Lever IJ,Rice AS.Cannabinoids and pain.Handb Exp Pharmacol,2007,177:265-306.
  • 4Wilson RI,Nicoll RA.Endocannabinoid signaling in the brain.Science,2002,296:678-682.
  • 5Ameri A.The effects of cannabinoid on the brain.Prog Neurobiol,1999,58:315-348.
  • 6Graham ES,Ashton JC,Glass M.Cannabinoid Receptors:A brief history and "what's hot".Front Biosci,2009,1:944-957.
  • 7Vaughan CW,Connor M,Bagley EE.Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.Mol Pharmacol,2000,57:288-295.
  • 8Niehaus JL,Liu Y,Wallis KT,et al.CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP la.Mol Pharmacol,2007,72:1557-1566.
  • 9Romero-Sandoval A,Nutile-McMenemy N,DeLeo JA.Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury.Anesthesiology,2008,108:722-734.
  • 10Beltramo M.Cannabinoid type 2 receptor as a target for chronic-pain.Mini Rev Med Chem,2009,9:11-25.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部